Back to News
Stifel reiterates Buy on Definium Therapeutics stock, $60 target
Source: Investing.com
The provided article text contains only "403" (no readable news content), so no themes, financial figures, or impact can be extracted.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Trump waives broad new Russia sanctions and tariffs under Graham Act, citing national interest
- ECB's Lagarde says bond selloff will slow inflation
- Iran-backed Houthis strike Yemen’s Aden: What that means
- Christine Lagarde: IMFC Statement
- Why did CoreWeave stock get crushed this week? Look to this corner of the debt market for clues
- Solar power booms in Philippines as war on Iran spikes energy costs